Toll-Like Receptor 7 Protects From Atherosclerosis by Constraining “Inflammatory” Macrophage Activation | Zendy

Maria Salagianni | Zendy; Ioanna E. Galani | Zendy; Anna M. Lundberg | Zendy; Constantinos H. Davos | Zendy; Aimilia Varela | Zendy; Ariana Gavriil | Zendy; LeoPekka Lyytikäinen | Zendy; Terho Lehtimäki | Zendy; Fragiska Sigala | Zendy; Lasse Folkersen | Zendy; Vassilis G. Gorgoulis | Zendy; Sébastien Lenglet | Zendy; Fabrizio Montecucco | Zendy; François Mach | Zendy; Ulf Hedin | Zendy; Göran K. Hansson | Zendy; Claudia Monaco | Zendy; Evangelos Andreakos | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Toll-Like Receptor 7 Protects From Atherosclerosis by Constraining “Inflammatory” Macrophage Activation

Author(s) -

Maria Salagianni,

Ioanna E. Galani,

Anna M. Lundberg,

Constantinos H. Davos,

Aimilia Varela,

Ariana Gavriil,

LeoPekka Lyytikäinen,

Terho Lehtimäki,

Fragiska Sigala,

Lasse Folkersen,

Vassilis G. Gorgoulis,

Sébastien Lenglet,

Fabrizio Montecucco,

François Mach,

Ulf Hedin,

Göran K. Hansson,

Claudia Monaco,

Evangelos Andreakos

Publication year - 2012

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.111.067678

Subject(s) - medicine , macrophage , inflammation , toll like receptor , receptor , immunology , innate immune system , microbiology and biotechnology , biochemistry , in vitro , biology , chemistry

Toll-like receptors (TLRs) have long been considered to be major culprits in the development of atherosclerosis, contributing both to its progression and clinical complications. However, evidence for most TLRs beyond TLR2 and TLR4 is lacking.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research